Drug
YTS109 clinical trials
- studies test it
- 11
- open now
- 9
- in phase 3
- 0
- first study started
- 2025
Keep track of what changes. Save the YTS109 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
11 studies that test it; most in 2025 (9)
| Year | Studies |
|---|---|
| 2025 | 9 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 11
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 3
China Immunotech (Beijing) Biotechnology Co., Ltd. (8) · Children's Hospital of Fudan University (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) · Institute of Hematology & Blood Diseases Hospital, China (1)
Studies
Open first, then newest update. How each study uses YTS109 is read from its arms, and is right about nine times in ten.
Testing it · 11
- Research on YTS109 Cell in Patients With Recurrent/Refractory Autoimmune Hemolytic AnemiaNot yet recruitingPhase 1China Immunotech (Beijing) Biotechnology Co., Ltd.NCT07453836Written as YTS109 cell
- A Clinical Study of YTS109 Cell in R/R Autoimmune DiseasesRecruitingPhase 1China Immunotech (Beijing) Biotechnology Co., Ltd.NCT06978647Written as YTS109 cell
- A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune DiseasesRecruitingPhase 1China Immunotech (Beijing) Biotechnology Co., Ltd.NCT07123519Written as YTS109 cell
- A Clinical Study of YTS109 Cell for R/R Autoimmune DiseasesRecruitingPhase 1China Immunotech (Beijing) Biotechnology Co., Ltd.NCT07104721Written as YTS109 cell
- An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune DiseasesRecruitingPhase 1China Immunotech (Beijing) Biotechnology Co., Ltd.NCT07236762Written as YTS109 cell
- Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune DiseasesRecruitingPhase 1China Immunotech (Beijing) Biotechnology Co., Ltd.NCT07236801Written as YTS109 cell
- YTS109 in Pediatric Relapsed/Refractory Autoimmune DiseasesNot yet recruitingPhase 1Children's Hospital of Fudan UniversityNCT07439029Written as YTS109 cell
- A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic AnemiaNot yet recruitingPhase 1Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyNCT07287930Written as YTS109 cell
- A Study of YTS109 Cell Injection in Subjects With Relapsed/Refractory Autoimmune Hemolytic AnemiaNot yet recruitingPhase 1Institute of Hematology & Blood Diseases Hospital, ChinaNCT06770504Written as YTS109
- A Clinical Study of YTS109 Cell in R/R Systemic Lupus ErythematosusTerminatedPhase 1China Immunotech (Beijing) Biotechnology Co., Ltd.NCT06943937Written as YTS109 cell injection
- A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic AnemiaCompletedPhase 1China Immunotech (Beijing) Biotechnology Co., Ltd.NCT07075484Written as YTS109 cell